CDMOs: The Modern Backbone of Biopharmaceutical Development: CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS CAN HELP STREAMLINE DRUG DEVELOPMENT.

Contract Development and Manufacturing Organizations (CDMOs) play a crucial role in the biopharmaceutical industry by offering specialized support, knowledge, and infrastructure to expedite the drug development process. Biopharmaceuticals, which are produced in living cells, have seen significant growth and offer high specificity and efficacy. However, developing these complex therapeutic products presents operational and technological challenges. Partnering with a CDMO can increase the speed, reliability, and reproducibility of drug development protocols, reduce risk, provide regulatory support, and offer opportunities for scale-up. The advantages of CDMO partnerships were highlighted during the COVID-19 pandemic, where collaboration with a CDMO helped researchers streamline and optimize the production of a potential biotherapeutic vaccine. Overall, CDMOs provide a strategic advantage for companies looking to accelerate drug development pathways and turn innovative ideas into actual products. [Extracted from the article]